Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20 monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma-Reference-Cited by-同舟云学术

Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20 monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma

Published:2014-01-25 Issue:3 Volume:5 Page:726-739
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Montraveta Arnau¹,Xargay-Torrent Sílvia¹,López-Guerra Mónica¹,Rosich Laia¹,Pérez-Galán Patricia¹,Salaverria Itziar¹,Beà Silvia¹,Kalko Susana G.²,de Frias Mercè³,Campàs Clara³,Roué Gaël¹,Colomer Dolors¹⁴

Affiliation:

1. Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

2. Bioinformatics Core Facility, IDIBAPS, Barcelona, Spain

3. Advancell-Advanced In Vitro Cell Technologies S.A., Barcelona, Spain

4. Hematopathology Unit, Hospital Clínic, Barcelona, Spain

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma;International Journal of Molecular Sciences;2023-03-13

2. 2‑Cl‑IB‑MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and liver cancer cell lines;International Journal of Molecular Medicine;2022-01-18

3. Potential and promising anticancer drugs from adenosine and its analogs;Drug Discovery Today;2021-06

4. Acadesine Circumvents Azacitidine Resistance in Myelodysplastic Syndrome and Acute Myeloid Leukemia;International Journal of Molecular Sciences;2019-12-25

5. The Role of AMPK/mTOR Modulators in the Therapy of Acute Myeloid Leukemia;Current Medicinal Chemistry;2019-07-01